Cargando…
Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity
The live attenuated yellow fever vaccine 17D (YF-17D) is one of the most effective vaccines available, with a 65-yr history of use in >400 million people globally. Despite this efficacy, there is presently no information about the immunological mechanisms by which YF-17D acts. Here, we present da...
Autores principales: | Querec, Troy, Bennouna, Soumaya, Alkan, Sefik, Laouar, Yasmina, Gorden, Keith, Flavell, Richard, Akira, Shizuo, Ahmed, Rafi, Pulendran, Bali |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118210/ https://www.ncbi.nlm.nih.gov/pubmed/16461338 http://dx.doi.org/10.1084/jem.20051720 |
Ejemplares similares
-
Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus
por: Kwissa, Marcin, et al.
Publicado: (2007) -
Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease
por: Belsher, Jon L., et al.
Publicado: (2007) -
Learning vaccinology from viral infections
por: Ahmed, Rafi, et al.
Publicado: (2011) -
Toll-Like Receptor Expression and Responsiveness of Distinct Murine Splenic and Mucosal B-Cell Subsets
por: Gururajan, Murali, et al.
Publicado: (2007) -
Absence of transmission of vYF next generation Yellow Fever vaccine in mosquitoes
por: Bellone, Rachel, et al.
Publicado: (2022)